Alfa Cytology
Alfa Cytology, a research solutions provider, focused on cancer therapeutic development and preclinical studies. From the complex phases of target discovery to IND application, we offer a seamless experience. Alfa Cytology specializes in providing comprehensive and efficient preclinical research services to meet the diverse needs of drug development. Our services include drug efficacy studies, pharmacokinetic studies, drug safety evaluations, etc.
Industries
Nr. of Employees
medium (51-250)
Products
Antibody Drug Conjugate Development Services
Development of antibody-drug conjugates combining monoclonal antibodies with cytotoxic drugs for targeted cancer therapy.
Antibody Optimization and Engineering Service
Engineering and optimization of antibody candidates to improve therapeutic or diagnostic performance in cancer treatment.
Antibody-Toxin Conjugate (ATC) Development Services
Development of antibody-toxin conjugates combining tumor-targeting antibodies with potent toxins for cancer therapy.
Cancer Stem Cells Inhibitor Development Services
Development services for inhibitors targeting cancer stem cells to disrupt their self-renewal and tumor-initiating capacity.
CAR T-cell Therapy Development Services for Cancer
Development of chimeric antigen receptor (CAR) T-cell therapies for targeted immunotherapy against cancer.
Cell Characterization Services
Comprehensive analysis of cell types, phenotypes, genetic and functional properties to support cancer cell therapy development.
Antibody Drug Conjugate Development Services
Development of antibody-drug conjugates combining monoclonal antibodies with cytotoxic drugs for targeted cancer therapy.
Antibody Optimization and Engineering Service
Engineering and optimization of antibody candidates to improve therapeutic or diagnostic performance in cancer treatment.
Antibody-Toxin Conjugate (ATC) Development Services
Development of antibody-toxin conjugates combining tumor-targeting antibodies with potent toxins for cancer therapy.
Cancer Stem Cells Inhibitor Development Services
Development services for inhibitors targeting cancer stem cells to disrupt their self-renewal and tumor-initiating capacity.
CAR T-cell Therapy Development Services for Cancer
Development of chimeric antigen receptor (CAR) T-cell therapies for targeted immunotherapy against cancer.
Cell Characterization Services
Comprehensive analysis of cell types, phenotypes, genetic and functional properties to support cancer cell therapy development.